10.1002/ejoc.201801511
European Journal of Organic Chemistry
FULL PAPER
(m), 536 (m). HRMS ((+)-ESI): m/z = 217.10131 (calcd. 217.10118 for
C17H13, [cation - HNMe2]+, 262.15896 (calcd. 262.15903 for C19H20N+,
[cation + H]+), 603.23742 (calcd. 603.23694 for C38H40BrN2+, [2cation +
2H + 79Br-]+, 605.23628 (calcd. 605.23550 for C38H40BrN2+, [2cation + 2H
(NCH3), 51.29 and 54.47 (CHbridgehead), 123.25–145.77 (10 CPh signals),
129.99 (C=C), 147.37 (C=C), 167.82 (C=N). IR (KBr): 휈̃ [cm-1] = 3061 (m),
3019 (m), 2965 (m), 2911 (m), 2858 (m), 1602 (s), 1456 (s), 1340 (m),
1276 (m), 1254 (s), 1229 (m), 1188 (m), 1149 (m), 1016 (m), 907 (m),
835 (m), 748 (s), 701 (s), 624 (m), 586 (s). HRMS ((+)-ESI): m/z =
322.15969 (calcd. 322.15903 for C24H20N+, [M + H]+). C24H19N (321.42
g/mol) calcd. C 89.68, H 5.96, N 4.36; found C 87.01, H 5.94, N 3.20.
+
81Br-]+. C19H20BrN (342.28 g/mol): calcd. C 66.67, H 5.89, N 4.09; found
C 65.52, H 5.83, N 4.47.
1-(3',6'-Diphenyl-[1,1':2',1''-terphenyl]-4'-yl)-N,N-
dimethylmethanaminium Bromide (30): Preparation as described for
29 from propyne iminium salt 2 (278 mg, 1.20 mmol), tetracyclone (462
mg, 1.20 mmol) and LiAlH4 (500 µL, 1.20 mmol, 2.4 M in THF). Yield:
609 mg (1.17 mmol, 98%), off-white solid, m.p. 284.0–285.2 °C. 1H NMR
(CDCl3, 500.14 MHz): [ppm] = 2.61 (d, 3J = 4.99 Hz, 6 H, N(CH3)2),
4.29 (d, 3J = 5.61 Hz, 2 H, NCH2), 6.66–6.68 (m, 2 H, HPh), 6.77–6.79 (m,
2 H, HPh), 6.83–6.84 (m, 3 H, HPh), 6.90–6.91 (m, 3 H, HPh), 6.97–6.98 (m.
2 H, HPh), 7.09–7.21 (m, 6 H, HPh), 7.30–7.31 (m, 2 H, HPh), 8.18 (s, 1 H,
HPh), 11.40 (s, br, 1 H, NH). 13C NMR (CDCl3, 125.79 MHz): [ppm] =
42.87 (N(CH3)2), 58.42 (NCH2), 125.82–142.65 (21 CPh signals). IR (KBr):
휈̃ [cm-1] = 1440 (m), 699 (s). HRMS ((+)-ESI): m/z = 440.23696 (calcd.
440.23728 for C33H30N+, [cation + H]+). C33H30BrN (520.51 g/mol): calcd.
C 76.15, H 5.81, N 2.69; found C 75.82, H 5.94, N 2.79.
1-(Bicyclo[2.2.1]hepta-2,5-dien-2-yl)-N-methyl-1-phenylmethanimine
(34): Iminium salt 17b (1.39 g, 3.87 mmol) was dissolved in THF (9 mL)
and added dropwise to LiHMDS (10.0 mL, 10.0 mmol, 1 M in THF) at
room temperature. Stirring was continued for 5 min whereupon the
reaction was quenched with aqueous Na2CO3 and extraced with CH2Cl2.
The organic phase was separated, dried over Na2SO4 and evaporated to
dryness under reduced pressure. The residue was dissolved in
cyclohexane/ethyl acetate (2:1) and quickly filtered through a short pad of
Al2O3. Removal of the solvent gave the crude imine 28 (655 mg, 3.13
mmol, 81%) as an orange oil. Further purification failed because of the
instability of 34. 1H NMR (CDCl3, 400.13 MHz): [ppm] = 2.00–2.03 (m, 2
H, CH2), 3.05 (s, 3 H, NCH3), 3.49 (s, 1 H, Hbridgehead), 4.11 (s, 1 H,
Hbridgehead), 6.34 (d, 3J = 3.06 Hz, 1 H, HC=C), 6.63–6.65 (m, 1 H,
HC=CH), 6.88–6.90 (m, 1 H, HC=CH), 6.95–6.97 (m, 2 H, HPh), 7.24–
7.28 (m, 3 H, HPh). 13C NMR (CDCl3, 100.61 MHz): [ppm] = 40.10
(NCH3), 49.58 and 51.20 (Cbridgehead), 72.72 (CH2), 127.46 (CPh), 127.97
(CPh), 128.16 (CPh), 137.03 (CPh), 142.97 (HC=CH), 143.41 (HC=CH),
149.87 (C=CH), 160.05 (C=CH), 167.22 (C=N). IR (NaCl): 휈̃ [cm-1] =
3057 (s), 3022 (s), 2970 (s), 2936 (s), 2865 (s), 2799 (m), 1635 (s), 1598
(s), 1553 (m), 1490 (m), 1446 (s), 1380 (m), 1328 (s), 1299 (s), 1250 (m),
1180 (m), 1091 (m), 1053 (m), 999 (m), 916 (m), 840 (m), 765 (m), 702
(s), 675 (m). MS ((+)-ESI): m/z (%) = 210.13 (100) [M + H]+. C15H15N
(209.29 g/mol): calcd. C 86.08, H 7.22, N 6.69.
5',6'-Diphenyl-[1,1':2',1''-terphenyl]-3'-carbaldehyde (31): Propyne
iminium salt 2 (109 mg, 0.47 mmol) was dissolved in CH2Cl2 (5 mL) and
MeCN (2 mL) and tetraphenylcyclopentadienone (181 mg, 0.47 mmol)
was added. After stirring for 15 min, a saturated aqueous K2CO3 solution
was added and the mixture was extracted with ether. The organic layer
was separated, dried with Na2SO4, and the volatiles were removed under
reduced pressure. The residue was purified by flash chromatography
(cyclohexane/EtOAc = 80:1) which gave 31 (183 mg, 0.45 mmol, 95%)
as a slightly violet solid. M.p. 205.1–207.0 °C. 1H NMR (CDCl3, 400.13
MHz): [ppm] = 6.77–6.84 (m, 4 H, HPh), 6.90–6.95 (m, 6 H, HPh), 7.11–
7.21 (m, 10 H, HPh), 8.18 (s, 1 H, HPh), 9.84 (s, 1 H, C(O)H). 13C NMR
(CDCl3, 100.62 MHz): [ppm] = 126.00–145.71 (22 CPh signals), 192.69
(C=O). IR (KBr): 휈̃ [cm-1] = 1689 (s), 1577 (m), 1443 (m), 1385 (m), 1074
(m), 761 (m), 702 (s). MS (CI, 100 eV): m/z (%) = 411 (100) [M + H]+.
C31H22O (410.52 g/mol): calcd. C 90.70, H 5.40; found C 90.80, H 5.56.
(6Z,12Z)-5,11-Dimethyl-6,12-diphenyl-1,4,4a,5,7,10,10a,11-octahydro-
1,4:7,10-dimethanodibenzo[b,f][1,5]diazocine (35): Norbornadiene
17b (850 mg, 2.37 mmol) was dissolved in CH2Cl2 (40 mL) and NaOMe
(439 µL, 2.39 mmol, 30 wt. % in MeOH) was added at room temperature.
After stirring for 10 min, the mixture was filtrated and the volatiles were
evaporated under reduced pressure. The brown residue was purified by
chromatography (SiO2, cyclohexane/EtOAc
= 40:1, Rf = 0.45). A
1-(3',6'-Diphenyl-[1,1':2',1''-terphenyl]-4'-yl)-N-methyl-1-
colorless solid was obtained, which was a mixture of the diastereomeric
diazocine derivatives 35 (337 mg, 0.81 mmol, 68%);with a molar ratio of
35A, 35B and 35C = 1 : 0.45 : 0.30. M.p. 205 °C. 1H NMR (CDCl3,
400.13 MHz): 35A: [ppm] = 1.49–1.59 (m, 2 H), 1.62–1.65 (m, 2 H),
1.97 (s, 3 H, NCH3), 2.28 (s, 3 H, NCH3), 3.03 (s, 1 H, Hbridgehead), 3.08–
3,09 (m, 1 H, Hbridgehead), 3.09–3.10 (m, 1 H, Hbridgehead), 3.52 (s, 1 H,
Hbridgehead), 3.83 (s, 1 H, NCH), 4.49 (d, J = 3.63 Hz, 1 H, NCH), 6.06 (dd,
J = 5.44, 2.99 Hz, 1 H, HC=CH), 6.14 (dd, J = 5.52, 2.83 Hz, 1 H,
HC=CH), 6.38 (dd, J = 5.40, 3.28 Hz, 1 H, HC=CH), 6.43 (dd, J = 5.58,
3.44 Hz, 1 H, HC=CH), 7.27–7.47 (m, 10 H, HPh); selected signals of 35B
and 35C: (CDCl3, 500.14 MHz): [ppm] = 2.00 (s, 6 H, NCH3, 35B), 2.24
(s, 6 H, NCH3, 35C), 2.98 (s, 2 H, Hbridgehead, 35C), 3.08–3.09 (m, 2 H,
phenylmethanimine (32): Iminium salt 18b (1.00 g, 1.54 mmol) was
dissolved in CH2Cl2 (8 mL) and added dropwise to triethylamine (10 mL,
72 mmol) in CH2Cl2 (50 mL). After stirring for 15 min, the volatile
components were removed under reduced pressure and the residue was
washed with several portions of cyclohexane. The combined organic
extracts were evaporated to dryness and the residue was purified by
column chromatography (cyclohexane/ethyl acetate = 10:1, Rf = 0.36).
Yield: 546 mg (1.09 mmol, 71%), white solid, m.p. 199.3–200.4 °C. 1H
NMR (CDCl3, 400.13 MHz): [ppm] = 3.25 (s, 3 H, NCH3), 6.60 (s, br, 1
H, HPh), 6.71–6.75 (m, 3 H, HPh), 6.79–6.91 (m, 11 H, HPh), 7.09–7.12 (m,
5 H, HPh), 7.19–7.25 (m, 4 H, HPh), 7.49–7.52 (m, 2 H, HPh). 13C NMR
(CDCl3, 100.61 MHz): [ppm] = 42.21 (NCH3), 125.64–142.14 (26 CPh
signals), 169.39 (C=N). IR (KBr): 휈̃ [cm-1] = 3056 (m), 3026 (m), 2925 (s),
2849 (s), 1711 (m), 1626 (m), 1599 (m), 1493 (m), 1444 (s), 1265 (m),
1027 (m), 762 (m), 697 (s). MS (CI, 100 eV): m/z (%) = 500 (100) [M]+,
422 (7) [M - Ph]+. C38H29N (499.66 g/mol): calcd. C 91.35, H 5.85, N 2.80;
found C 91.49, H 6.03, N 2.68.
Hbridgehead, 35B), 3.16 (s, 2 H, Hbridgehead, 35B), 3.45 (s, 2 H, Hbridgehead
,
35C), 3.68 (s, 2 H, NCH, 35C), 4.65 (d, J = 3.59 Hz, 2 H, NCH, 35B),
6.01 (dd, J = 5.51, 2.90 Hz, 2 H, HC=CH, 35C), 6.19 (dd, J = 5.52, 2.84
Hz, 2 H, HC=CH, 35B), 6.33 (dd, J = 5.50, 3.10 Hz, 2 H, HC=CH, 35C),
6.44 (dd, J = 5.61, 3.10 Hz, 2 H, HC=CH, 35B). 13C NMR (CDCl3, 125.79
MHz), signals of all isomers: [ppm] = 33.30, 33.62, 34.15, 34.31, 46.75,
47.59, 48.83, 48.86, 50.02, 50.10, 50.29, 51.68, 51.84, 115.47, 117.23,
120.47, 122.10, 127.11–138.19 (20 signals), 140.58, 140.69, 140.87,
141.01, 142.87, 143.59, 143.85, 144.62. IR (KBr): 휈̃ [cm-1] = 3056 (m),
3015 (m), 2969 (s), 2943 (s), 2867 (s), 2799 (m), 1635 (s), 1597 (m),
1444 (s), 1379 (s), 1324 (s), 1055 (s). MS (CI, 100 eV): m/z (%) = 419
(37) [M + H]+, 352 (24) [M - C5H6]+, 286 (100) [M - 2C5H6]+, 210 (42) [M/2
+ H]+. C30H30N2 (418.58 g/mol): calcd. C 86.08, H 7.22, N 6.69; found C
85.96, H 7.38, N 6.70.
1-(9,10-Dihydro-9,10-ethenoanthracen-11-yl)-N-methyl-1-
phenylmethanimine (33): Iminium salt 19b (868 mg, 1.84 mmol) was
dissolved in CH2Cl2 (6 mL) and triethylamine (306 µL, 2.21 mmol) was
added. After stirring for 5 min, aqueous Na2CO3 was added followed by
extraction with CH2Cl2. The organic layer was dried over Na2SO4 and
filtered through Al2O3. Evaporation of the solvent gave crude 33 (467 mg,
1.45 mmol, 79%). Further purification by column chromatography or
recrystallization failed. M.p. 165.8–167.9 °C. 1H NMR (CDCl3, 400.13
MHz): [ppm] = 3.12 (s, 3 H, NCH3), 5.02 (d, 3J = 1.55 Hz, 1 H,
Hbridgehead), 5.33 (d, 3J = 5.95 Hz, 1 H, Hbridgehead), 6.95 (dd, J = 5.97, 1.73
Hz, 1 H, HC=C), 7.02–7.10 (m, 4 H, HPh), 7.28–7.31 (m, 4 H, HPh), 7.36–
7.42 (m, 5 H, HPh). 13C NMR (CDCl3, 100.61 MHz): [ppm] = 42.18
(3-Methoxybicyclo[2.2.1]hept-5-en-2-yl)(phenyl)methanone
(36):
Norbornadiene 17b (1.26 g, 3.49 mmol) was dissolved in MeOH (10 mL)
and slowly added to a solution of NaOMe (6.48 mL, 35 mmol, 30 wt. % in
15
This article is protected by copyright. All rights reserved.